Suppr超能文献

帕金森病中的皮质抑制。

Cortical disinhibition in Parkinson's disease.

机构信息

CINAC, Hospital Universitario HM Puerta del Sur, Universidad CEU-San Pablo, Móstoles, Madrid, Spain.

CIBERNED, Instituto de Salud Carlos III, Madrid, Spain.

出版信息

Brain. 2020 Dec 5;143(11):3408-3421. doi: 10.1093/brain/awaa274.

Abstract

In Parkinson's disease, striatal dopamine depletion produces profound alterations in the neural activity of the cortico-basal ganglia motor loop, leading to dysfunctional motor output and parkinsonism. A key regulator of motor output is the balance between excitation and inhibition in the primary motor cortex, which can be assessed in humans with transcranial magnetic stimulation techniques. Despite decades of research, the functional state of cortical inhibition in Parkinson's disease remains uncertain. Towards resolving this issue, we applied paired-pulse transcranial magnetic stimulation protocols in 166 patients with Parkinson's disease (57 levodopa-naïve, 50 non-dyskinetic, 59 dyskinetic) and 40 healthy controls (age-matched with the levodopa-naïve group). All patients were studied OFF medication. All analyses were performed with fully automatic procedures to avoid confirmation bias, and we systematically considered and excluded several potential confounding factors such as age, gender, resting motor threshold, EMG background activity and amplitude of the motor evoked potential elicited by the single-pulse test stimuli. Our results show that short-interval intracortical inhibition is decreased in Parkinson's disease compared to controls. This reduction of intracortical inhibition was obtained with relatively low-intensity conditioning stimuli (80% of the resting motor threshold) and was not associated with any significant increase in short-interval intracortical facilitation or intracortical facilitation with the same low-intensity conditioning stimuli, supporting the involvement of cortical inhibitory circuits. Short-interval intracortical inhibition was similarly reduced in levodopa-naïve, non-dyskinetic and dyskinetic patients. Importantly, intracortical inhibition was reduced compared to control subjects also on the less affected side (n = 145), even in de novo drug-naïve patients in whom the less affected side was minimally symptomatic (lateralized Unified Parkinson's Disease Rating Scale part III = 0 or 1, n = 23). These results suggest that cortical disinhibition is a very early, possibly prodromal feature of Parkinson's disease.

摘要

在帕金森病中,纹状体多巴胺耗竭会导致皮质-基底节运动回路的神经活动发生深刻改变,从而导致运动输出功能障碍和帕金森症。运动输出的一个关键调节因子是初级运动皮层中兴奋和抑制之间的平衡,这可以通过经颅磁刺激技术在人类中进行评估。尽管经过了几十年的研究,帕金森病患者皮质抑制的功能状态仍然不确定。为了解决这个问题,我们在 166 名帕金森病患者(57 名未经左旋多巴治疗,50 名无运动障碍,59 名运动障碍)和 40 名健康对照者(与未经左旋多巴治疗组年龄匹配)中应用了成对脉冲经颅磁刺激方案。所有患者均在停药状态下接受研究。所有分析均采用全自动程序进行,以避免确认偏倚,并且我们系统地考虑并排除了几个潜在的混杂因素,如年龄、性别、静息运动阈值、肌电图背景活动和单脉冲测试刺激引起的运动诱发电位的幅度。我们的结果表明,与对照组相比,帕金森病患者的短程皮质内抑制降低。这种皮质内抑制的降低是在相对低强度的刺激条件下(80%的静息运动阈值)获得的,并且与短程皮质内易化或相同低强度刺激条件下的皮质内易化没有任何显著增加相关,支持皮质抑制回路的参与。未经左旋多巴治疗的、无运动障碍的和有运动障碍的患者的短程皮质内抑制均相似降低。重要的是,即使在多巴胺药物初治患者中,即受影响较小的一侧症状最小(偏侧帕金森病评定量表第三部分= 0 或 1,n=23),皮质内抑制也比对照组降低。这些结果表明,皮质去抑制是帕金森病的一个非常早期、可能是前驱的特征。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验